| Literature DB >> 27881064 |
Mauro Serafini1, Ilaria Peluso.
Abstract
The health benefits of plant food-based diets could be related to both integrated antioxidant and antiinflammatory mechanisms exerted by a wide array of phytochemicals present in fruit, vegetables, herbs and spices. Therefore, there is mounting interest in identifying foods, food extracts and phytochemical formulations from plant sources which are able to efficiently modulate oxidative and inflammatory stress to prevent diet-related diseases. This paper reviews available evidence about the effect of supplementation with selected fruits, vegetables, herbs, spices and their extracts or galenic formulation on combined markers of redox and inflammatory status in humans. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.Entities:
Keywords: Antioxidants; functional foods; human; inflammation; oxidative stress; plant foods.
Mesh:
Substances:
Year: 2016 PMID: 27881064 PMCID: PMC5427773 DOI: 10.2174/1381612823666161123094235
Source DB: PubMed Journal: Curr Pharm Des ISSN: 1381-6128 Impact factor: 3.116
Overview of the reviewed intervention studies with vegetables and vegetable extracts in humans: characteristics, study design and effect on markers of redox, oxidative and inflammatory status.
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
| Carrot (juice) | 16 fl oz | Healthy | Longitudinal, 3 months | NEAC↑ | CRP and IL-1↔ | [ |
| Tomato (juice) | 280 ml | Healthy women | Longitudinal, 2 months | TBARS ↓ | Adiponectin ↑ | [ |
| Tomato-derived Lyc-O-Mato (capsules) | 45 mg lycopene | Asthmatic | Parallel, 14 weeks | IsoP↔ | CRP ↑ | [ |
| Tomato-derived Lyc-O-Mato (capsules). | 30 mg lycopene | Obese | Longitudinal, 4 weeks | Dienes ↔ | CRP, TNF-α and IL-6 ↔ | [ |
| Tomato-derived Lyc-O-Mato (drink). | 250 ml | Healthy | Crossover, 26 days | IsoP↔ | TNF-α and IFN-γ ex vivo ↓ | [ |
| Tomato-derived Lyc-O-Mato (extract) | 80 mg lycopene | Healthy | Longitudinal, 1 week; | MDA ↔ | CRP↔ | [ |
CRP: C reactive protein; IFN-γ: interferon gamma; IL: interleukin; IsoP: isoprostanes; MDA: malondialdehyde; NEAC: non-enzymatic antioxidant capacity; TBARS: thiobarbituric acid reactive substances; TNF-α: tumor necrosis factor alfa.
Overview of the reviewed intervention studies with fruits, fruit juices and fruits extracts in humans: characteristics, study design and effect on markers of redox, oxidative and inflammatory status.
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
| Bilberry (juice) | 330 ml | At least one risk factor for cardiovascular disease | Parallel, 4 weeks | NEAC, lipid peroxidation and GSH ↔ | CRP and IL-6 ↓ | [ |
| Cranberries (dried powder) | 1500 mg | Men with urinary tract infection | Parallel, 6 months | NEAC, SOD, MDA, GSH, GPX, CAT and AOPP ↔ | CRP ↔ | [ |
| Cranberry (juice) | 480 ml | Metabolic syndrome | Parallel, 8 weeks | NEAC ↑ | CRP↔ | [ |
| Cranberry (juice) | 0,7 litres | Metabolic syndrome | Parallel, 60 days | Lipid peroxidation and AOPP ↓ | Adiponectin ↑ | [ |
| Fermented papaya (sachets) | 9 g | Type 2 diabetic obese | Longitudinal, 2 and 6 weeks | 4-HNE ↔ | Oxidative burst ↑ | [ |
| Fermented papaya (supplement). | 9 g | Elderly | Crossover, 3 months | SOD, GPX and GSH ↔ | TNF-α and IL-6 ↓ | [ |
| Fermented papaya (supplement). | 9 g | HCV-related cirrhosis | Longitudinal, 6 months | GSH and GPX↑ | TNF-α↓ | [ |
| Fermented papaya (supplement). | 6 g | HCV-related cirrhosis | Parallel, 6 months | 4-HNE ↓ | TNF-α ex vivo ↓ | [ |
| Freeze-dried Strawberry | 50g | Women with metabolic syndrome | Longitudinal, 4 weeks | 4-HNE, MDA ↓ | CRP and adiponectin ↔ | [ |
| Freeze-dried strawberry | 25 g (low) | Obese with elevated serum lipids | Parallel, 12 weeks | MDA and HNE ↓ | CRP ↔ | [ |
| Freeze-dried strawberry | 50g | Type 2 diabetic | Parallel, 6 weeks | NEAC ↑ | CRP ↓ | [ |
| Freeze-dried whole grape (powder) | 46 g | Dyslipidemia | Crossover, 4 weeks | oxLDL, IsoP, SOD and GPX↔ | TNF-α, IL-6, IL-8 and NOX↔ | [ |
| Pomegranate (concentrated juice) | 50 g | Type 2 diabetic | Longitudinal, 4 weeks | NEAC ↑ | IL-6 and adiponectin ↓ | [ |
| Pomegranate (capsules) | 2 capsules (1.5g polyphenol). | obese with type 2 diabetes | Longitudinal, 4 weeks | 4-HNE, MDA ↓ | CRP ↔ | [ |
| Pomegranate (extract) | 1g | Hemodialysis | Parallel, 6 months | NEAC, AOPP, 8-OHdG and ox-LDL↔ | IL-6 and CRP ↔ | [ |
| Pomegranate (extract) | 2 capsules (500 mg, 40% ellagic acid) | Rheumatoid arthritis | Parallel, 8 weeks | MDA ↔ | CRP ↔ | [ |
| Pomegranate (extract) | 100mg | Overweight/obese | Parallel, 30 days | MDA ↓ | CRP and IL-6 ↓ | [ |
| Pomegranate juice + pomegranate (extract) | 100 mL Juice | Hemodialysis | Crossover | IsoP ↔ | CRP and IL-6 ↔ | [ |
| Pomegranate (juice) | 100ml | Hemodialysis | Parallel, during the first hour of a dialysis session | AOPP ↓ | MPO ↓ | [ |
| Pomegranate (juice) | 100 cc | Hemodialysis | Parallel, during each dialysis (3 times/ week), 1 year | MDA, AOPP and carbonyls ↓ | TNF-α, IL-6 and MPO ↓ | [ |
| Red grape (concentrated juice) | 100ml | Hemodialysis | Parallel, 2 weeks | NEAC ↑ | CRP ↔ | [ |
| Red grape (concentrated juice) | 100ml | Hemodialysis | Parallel, 2 weeks | oxLDL ↓ | CRP ↔ | [ |
| Rio red grapefruit | Half 3 times/day | Obese | Parallel, 6 weeks | IsoP ↔ | CRP ↔ | [ |
4-HNE: 4-hydroxynonenal; 8-OHdG: 8-hydroxy-2' –deoxyguanosine; AOPP: advanced oxidation protein products; CAT: catalase; CRP: C reactive protein; GPX: glutathione peroxidase; GSH: reduced glutathione; Hsp-70: heat shock protein 70; IFN-γ: interferon gamma; IL: interleukin; iNOS: inducible nitric oxide synthase; IsoP: isoprostanes; MDA: malondialdehyde; NEAC: non-enzymatic antioxidant capacity; NOX: NADPH-oxidase; oxLDL: oxidized low density lipoproteins; ROS: reactive oxygen species; SOD: superoxide dismutase; TNF-α: tumor necrosis factor alfa; HCV: Hepatitis C Virus.
Overview of the reviewed intervention studies with grape seeds in humans: characteristics, study design and effect on markers of redox, oxidative and inflammatory status.
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
| Grape seeds (capsules) | 1300 mg | CVD risk factors | Crossover, 1 month | NEAC, MDA and IsoP↔ | CRP and IL-6 ↔ | [ |
| Grape seed extract (added in yoghurt) | 2 g | CVDrisk factors | Crossover, 4 weeks | oxLDL and IsoP↔ | CRP↔ | [ |
| Grape seed extract (capsules) | 2 g | Overweight/obese first degree relatives of type 2 diabetic patients | Parallel, 8 weeks | week 8: | week 8: | [ |
| Grape seed extract (tablets) | 600 mg | Type 2 diabetes | Crossover, 4 weeks | NEAC ↔ | CRP ↓ | [ |
| Monomeric and oligomeric flavanols from grape seeds (capsules) | 200 mg | Male smokers | Parallel, 8 weeks | NEAC, SOD, CAT, GPX and IsoP↔ | CRP ↔ | [ |
CAT: catalase; CRP: C reactive protein; CVD: cardiovascular; GPX: glutathione peroxidase; GSH: reduced glutathione; GSSG: oxidized glutathione; IL: interleukin; IsoP: isoprostanes; MDA: malondialdehyde; NEAC: non-enzymatic antioxidant capacity; oxLDL: oxidized low density lipoproteins; SOD: superoxide dismutase; TBARS: thiobarbituric acid reactive substances; TNF-α: tumor necrosis factor alfa.
Overview of the reviewed intervention studies with herbs extracts in humans: characteristics, study design and effect on markers of redox, oxidative and inflammatory status.
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
| Ginseng based steroid Rg1 (capsule) | 5 mg Rg1 | Healthy | Crossover, one night and one hour before exercise | TBARS ↓ | IL6 ↔ | [ |
| Ginseng extract (capsule) | 250 mg, four capsules/day | Hyperlipidemic | Parallel, 8 weeks | PAB ↔ | CRP↔ | [ |
| Ginsenosides (intravenously) | 1.5 mL/kg (equal to 1.35 mg/kg ginsenosides and 0.15 mg/kg aconite alkaloid). | Children undergoing heart surgery for congenital heart defects | Parallel, 2 minutes before the start of cardiopulmonary bypass (CPB) and throughout the course of CPB. | MDA (1 and 2h after reperfusion) ↓ | IL-6 and LPS (1 and 2h after reperfusion)↓ | [ |
| 140 mg silymarin three times/day | Type 2 diabetes | Parallel, 45 days | SOD↑ | CRP↓ | [ | |
| Nettle ( | 100 mg /kg of body weight | 50 | Parallel, 8 weeks | NEAC ↑ | CRP and IL-6↓ | [ |
CRP: C reactive protein; GPX: glutathione peroxidase; IL: interleukin; NEAC: non-enzymatic antioxidant capacity; LPS: lipopolysaccharide; MDA: malondialdehyde; PAB: Pro-oxidant- Antioxidant Balance; SOD: superoxide dismutase; TBARS: thiobarbituric acid reactive substances; TNF-α: tumor necrosis factor α.
Overview of the reviewed intervention studies with green tea and green tea extracts in humans: characteristics, study design and effect on markers of redox, oxidative and inflammatory status.
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
| Green tea (Beverage) | 2.4 g instant green tea | Obese | Crossover, 5 days | IsoP ↓ | CRP and IL6 ↔ | [ |
| Green tea extract (Beverage) | 159 mg total catechins in 450ml | Male cyclists | Crossover, 21 days, | oxLDL and | CRP ↓ | [ |
| Green tea extract (capsule) | 379 mg (208 mg EGCG) | Obese, hypertensive patients | Parallel, 3 months | NEAC ↑ | TNF-α ↓ | [ |
| Green tea extract (capsule) | 1 g (483 mg of Camelia Sinensis powder and 100 mg of leaf extracts for a total of 68 mg catechins) | Chronic dialysis | Longitudinal, 3 and 6 months | oxLDL ↓ (only in 9 patients) | P22phox ↓ | [ |
| Green tea extract (Tablets) | 455 and 910 mg of catechins during a single hemodialysis session. | Haemodialysis patients | Crossover, bolus, 1 and 3h post-dialysis | peroxides ↓ | IL-8 and TNF-α receptor↓ | [ |
CRP: C reactive protein; EGCG: epigallocatechingallate; IL: interleukin; IsoP: isoprostanes; NEAC: non-enzymatic antioxidant capacity; oxLDL: oxidized low density lipoproteins; TBARS: thiobarbituric acid reactive substances; TNF-α: tumor necrosis factor alfa.
Overview of the reviewed intervention studies with spices extracts in humans: characteristics, study design and effect on markers of redox, oxidative and inflammatory status.
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|
| Curcumin (phytosome) | 200 mg | Healthy | Parallel, 48 hours prior and 24 hours after running test | NEAC↔ | CRP ↓ (24h) | [ | |
| Curcumin extracts (powder) | 400 mg (80 mg curcumin) | Healthy | Parallel, 4 weeks | NEAC↑ CAT↑ | CRP ↔ | [ | |
| Curcuminoids (capsules) | 4 g | Undergoing coronary artery bypass grafting | Parallel, 3 days before the surgery and 5 days after surgery | MDA↓ | CRP↓ | [ | |
| Turmeric (capsules) | 2 g | Type 2 diabetes on metformin therapy | Parallel, 4 weeks. | NEAC ↑ | CRP↓ | [ | |
| Turmeric (capsules) | 2.8 g | Overweight and obese women | Parallel, 4 weeks | IsoP and oxLDL↔ | CRP, IL-6, IL-8 and TNF-α ↔ | [ | |
| Ginger (capsule) | 1000 mg | Peritoneal dialysis | Parallel, 10 weeks | MDA↔ | CRP↔ | [ | |
| Ginger (capsules) | 3 g | Type 2 diabetes | Parallel, 3 months | NEAC↑ | CRP↓ | [ | |
| Ginger extract (enteral feeding) | 120 mg | Acute respiratory distress syndrome | Parallel, 5 and 10 days | GSH (day 5)↑ | IL-1 ↔ | [ | |
CAT: catalase; CRP: C reactive protein; GPX: glutathione peroxidase; GSH: reduced glutathione; IL: interleukin; IsoP: isoprostanes; MDA: malondialdehyde; MPO: myeloperoxidase; NEAC: non-enzymatic antioxidant capacity; oxLDL: oxidized low density lipoproteins; SOD: superoxide dismutase; TNF--α: tumor necrosis factor alfa.
Overview of the reviewed intervention studies with beverages with mixed plant food composition in humans: characteristics, study design and effect on markers of redox, oxidative and inflammatory status.
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
| Mixed fruit beveragea | 120 ml | Healthy | Longitudinal, 12 weeks | TBARS ↔ | CRP↔ | [ |
| Citrus-based juice with melanocarpab. | 300 ml | Metabolic syndrome | Parallel, 6 months | oxLDL↓ | CRP↓ | [ |
| Mixed fruit and vegetable beverageb | 360 mg/L polyphenols; 170 mg total proanthocyanidins and 9 mg anthocyanins in single dose | Healthy | Parallel, acute (0-4h) | IsoP↓ | CRP↔ | [ |
| Pineapple, black currant and plum. | 500 ml (32 mg anthocyanins, 2.5 mg flavan-3-ols and 20 mg flavonols) | Overweight | Crossover, acute, post-prandial with high fat and carbohydrates meal (0-8h) | IsoP↔ | TNF- α, IL-6 and IL-17↓ | [ |
CRP: C reactive protein; IFN: interferon; IL: interleukin; IsoP: isoprostanes; MDA: malondialdehyde; NEAC: non-enzymatic antioxidant capacity; TBARS: thiobarbituric acid reactive substances; TNF- α: tumor necrosis factor alfa. Mixed fruit beveragea: Acai pulp, pomegranate, wolfberry, camu camu, passion fruit, aronia, acerola, bilberry, apricot, purple grape, white grape, lychee, banana, kiwi, pear, cranberry, blueberry and prune. Citrus-based juiceb. juice citrus (95%) with 5% of A. melanocarpa extract. Mixed fruit and vegetable beveragec: Coffee fruit extract, grape seed, North American wild blueberry, quercetin, resveratrol, bilberry, raspberry, cranberry, prune, tart cherry, strawberry, grape seed extract, broccoli sprouts, broccoli, tomato, carrot, spinach, kale, brussels sprout, pomegranate extract and acai pulp) dissolved in a blend of juices (grape, pomegranate, pear, apple, strawberry, chiloensis; acai, yumberry, rubra; cupuacu and camu and a standardized extract of Ashwagandha).
Overview of the reviewed intervention studies with extracts with mixed composition in humans: characteristics, study design and effect on markers of redox, oxidative and inflammatory status.
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|
| Capsule containing antioxidants, plant-food extracts and PUFA | Four capsules | Overweight | Crossover, 5 weeks | IsoP↓ | CRP ↔ | [ | |
| CHOLACTIV | Two capsule | Dyslipidemia | Parallel, 6 weeks | SOD ↔ | CRP ↓ | [ | |
| Fruits and vegetables capsules (FV)a | Three twice a day with meal | Healthy | Parallel, 60 days | SOD↑ | CRP↔ | [ | |
| Capsule containing: ginseng roots, mulberry leaf water extract and banana leaf water extract. | 6 g | Impaired glucose tolerance or mild T2D | Parallel, 24 weeks | oxLDL↓ | CRP↔ | [ | |
| Capsule containing powder concentrate derived from fruits and vegetablesc | Three twice a day with meal | Overweight and obese pre-menopausal women | Parallel, 8 weeks | 8 weeks: | 8 weeks: | [ | |
| Vitamins, minerals and mixed plant extractsd (Tablets) | 2 tablets | Healthy | Longitudinal, 4 weeks | oxLDL↓ | CRP↔ | [ | |
| Infusion of IMOD (urtica, carotenoids, urea, and selenium) | 125 mg of IMOD* | Severe sepsis | Parallel, 14 days | NEAC, lipid peroxidation and SH ↔ | TNF-α↓ | [ | |
| Powder containing: green tea extract, blueberry pomace extract, Soy protein complex | Soy protein complex | Healthy | Parallel, 2 weeks | NEAC, carbonyls and IsoP↔ | CRP, TNF-α IL-6 and IL-8 ↔ | [ | |
| Curcuminoids + piperine (capsules) | curcuminoids (1g) + piperine (10mg) | Metabolic syndrome | Parallel, 8 weeks | SOD↑ | CRP↓ | [ | |
| Mixed plant extracts and fish oil capsules) | One each supplement/day | Healthy | Parallel, 6 months | Carbonyls ↔ | CRP, TNF- α and IL-6↔ | [ | |
| Powder containing green tea extract (1g) + vitamin C and E | Twice/day and one hour before surgery‡ | Cancer patients | Parallel, three doses† | NEAC ↑ | CRP ↔ | [ | |
CRP: C reactive protein; GPX: glutathione peroxidase; IL: interleukin; IsoP: isoprostanes; MDA: malondialdehyde; MPO: myeloperoxidase; NEAC: non-enzymatic antioxidant capacity; oxLDL: oxidized low density lipoproteins; PUFA: polyunsaturated fatty acids; SH: sulphydrils; SOD: superoxide dismutase; TNF- α: tumor necrosis factor alfa; T2D: Type 2 diabetes. a: capsules blended fruit and vegetable juice powder concentrate derived from acerola cherry, apple, beet, broccoli, cabbage, carrot, cranberry, kale, orange, peach, papaya, parsley, pineapple, spinach, and tomato; b: bilberry, blackberry, black currant, blueberry, cranberry, Concord grape, elderberry, raspberry and red currant; c: acerola cherry, apple, bilberry, blackberry, black currant, blueberry, beetroot, broccoli, cabbage, carrot, Concord grape, cranberry, elderberry, kale, orange, peach, papaya, parsley, pineapple, raspberry, red currant, spinach and tomato; d: Citrus bioflavonoids, green coffee bean extract, pomegranate whole fruit extract, grape seed extract, blueberry fruit extract, green tea leaf extract, bitter melon fruit extract, prune skin extract, watercress herb 4:1 extract, Chinese cinnamon bark powder, Indian gum Arabic tree bark and heart wood extract, rosemary extract and artichoke leaf extract; *: in 100 ml of DW5% infused over 1 hour on the first day, then 8 ml of IMOD in 100 ml/d; ‡ pancreaticoduodenectomy; †: 2 the day before the operation and the third the day of surgery 3 h before the anaesthesia.
Overview of the reviewed intervention studies with cocoa products in humans: characteristics, study design and effect on markers of redox, oxidative and inflammatory status.
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
| Dark chocolate + | 36.9 g (Procyanidin 4.56mg/g) | Healthy | Longitudinal, 6 weeks treatment and 6-weeks washout period | NEAC, IsoP ↔ . | CRP ↔ | [ |
| Cocoa | 180 mg flavanols (low), | Obese | Crossover, 5 days | IsoP ↔ . | CRP↔, IL-6 ↑ | [ |
| Cocoa | 78 g of: | Pre-hypertensive or stage-1 hypertensive, high cholesterol | Parallel, 4 weeks | oxLDL ↔ | CRP and IL-6 ↔ | [ |
| Cocoa powder | 45.3 mg flavanols | Moderately hypercholesterolaemic | Cross-over, 4 wks | NEAC, MDA, Carbonyls ↔ | IL-10 ↓ | [96, |
CRP: C reactive protein; IL: interleukin; IsoP: isoprostanes; MDA: malondialdehyde; NEAC: non-enzymatic antioxidant capacity; oxLDL: oxidized low density lipoproteins; TNF-α: tumor necrosis factor alfa.